vTv Therapeutics (VTVT) Interest Coverage Ratio Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 40.09% |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -95.38% |
| Sep 30, 2025 | -44.37% |
| Dec 31, 2023 | -198.58% |
| Sep 30, 2023 | -381.11% |
| Jun 30, 2023 | -495.55% |
| Dec 31, 2022 | -260.46% |
| Sep 30, 2022 | -275.53% |
| Mar 31, 2022 | -881.80% |
| Dec 31, 2021 | -1,476.65% |
| Sep 30, 2021 | -429.30% |
| Dec 31, 2020 | 56.35% |
| Sep 30, 2020 | 3.94% |
| Jun 30, 2020 | -7.69% |
| Mar 31, 2020 | -17.15% |
| Dec 31, 2019 | 12.51% |
| Jun 30, 2019 | 91.40% |
| Mar 31, 2019 | 89.96% |
| Dec 31, 2018 | -27.37% |
| Sep 30, 2018 | 60.29% |
| Jun 30, 2018 | -1.07% |
| Mar 31, 2018 | 16.02% |
| Dec 31, 2017 | -140.22% |
| Sep 30, 2017 | 25.19% |
| Jun 30, 2017 | 69.10% |